Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round)and...
US tech needs a pivot to survive

US tech needs a pivot to survive

James Stranko Contributor James Stranko is a writer and independent advisor to American tech companies expanding abroad. He was on the founding team of Fuel, McKinsey’s practice serving VC firms and pre-IPO tech leaders. Daire Hickey Contributor Share on Twitter Daire...